Larazotide_Dosage, benefits & legal status
Also known as AT-1001, larazotide acetate, INN-202
An oral peptide studied for sealing a leaky gut, mainly in celiac disease.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is Larazotide?
Plain language first. The technical label stays, but it never stands alone.Overview
It works locally in the intestine to seal a 'leaky' gut barrier and has been studied mainly for celiac disease. It is not absorbed into the body.
Larazotide is an 8-amino-acid peptide that tightens the junctions between the cells lining your gut.
What it's used for
An oral peptide studied for sealing a leaky gut lining, mainly for celiac disease. It works in the gut and is not absorbed.
How does Larazotide work?
What it does in the body, and where.Larazotide is unusual here: it is designed specifically not to be absorbed. It works on the inside surface of your gut and never enters the bloodstream.
- 01It tightens the junctions between gut lining cellsThe seals between cells that determine what can pass from the gut into the body.
- 02It works in the gut cavity, not in your bloodWhich limits both its effects and its risks to the intestine itself.
- 03Celiac disease is what it was built forReducing the symptoms that break through when someone eating gluten-free encounters small amounts anyway.
- 04Phase 3 did not meet its endpointIt has been through large trials, which is more than most compounds here can say, and it did not clearly work.
Where this compound is thought to act.
What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Celiac disease symptoms despite a gluten-free diet, where the Phase 3 trial was stopped in 2022 for lack of benefitInvestigational
- Sealing a leaky gut lining generallyEarly research
The published record
84
Records indexed for Larazotide
63 in humans, 18 of them original studies.
31 registered trials, 12 with posted results.
Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 11 September 2026.

At a glance
Four things to know about Larazotide
Evidence
Investigational
Category
Healing and recovery
Common vial
Varies
Half-life
Not the right question
How much, and do you cycle it?
The range, and whether you take breaks.0.5 mg per dose, before meals. Not cycled in the trialsTrial dose
In the trials this was given continuously for the whole study period. No on/off schedule has been tested, so there is nothing to report beyond that.
How long does it stay in the body?
The half-life, and where the figure comes from.Not the right questionNo figure
Larazotide is designed to work inside the gut and not be absorbed into the bloodstream at all, so a blood half-life does not describe what it does.
Source: Paterson BM, et al. Aliment Pharmacol Ther 2007;26:757-766
You can compare this against the whole library to see where it sits.
What does it cost?
Typical dose and cost, in plain numbers.Larazotide is not injected
It is taken by mouth (oral).
Larazotide starts at $50.00 across 1 vendor.
2 listings, last read Sep 4, 2026. Shipping and card fees are not included.
How do you store it?
Before mixing, and after.Room temperature. Cool, dry, out of light.
Larazotide is taken as a pill or capsule. Keep it in its original container at room temperature, away from heat, humidity, and direct sun. No fridge or mixing needed. Check the expiration date on the bottle.
What are the side effects and cautions?
Known cautions and warnings for this compound.Who should avoid it
- No formal contraindications established
Stop and get help
- Signs of an allergic reaction
Common effects
- Comparable to placebo in trials, since it works in the gut and is not absorbed
- Its Phase 3 celiac trial was stopped in 2022 because it did not work well enough, not because it was unsafe
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is Larazotide approved?
And where the numbers on this page come from.No. Larazotide is not approved anywhere and is currently in company-run clinical trials. There is no legal route to obtain it outside a trial.
- Approval statusInvestigational
- RouteBy mouth (oral)
- CheckedSeptember 2026
What has happened recently
We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.
You can compare this against the whole library, or read how to check a seller.
- DoseFrom published clinical trials. Not approved by a regulator for this dose.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Sources
- Reviewed8 September 2026
What else is like Larazotide?
Others in Healing and recovery, side by side.If you're weighing Larazotide, it's worth reading Pentosan Polysulfate (PPS), Cerebrolysin, and Cortagen in the same class.
An oral peptide studied for sealing a leaky gut, mainly in celiac disease.
- Dose
- 0.5 mg per dose
- How often
- Before meals
A treatment for arthritis and painful bladder that acts like a joint lubricant.
- Dose
- 300 mg per day (100 mg three times a day)
- How often
- Weekly courses
An injectable brain-peptide blend used abroad for stroke and dementia recovery.
- Dose
- 10 up to 50 mL per day (start low, increase slowly)
- How often
- 10-20 day cycles
A bioregulator taken in courses for nerve and tissue recovery, with thin evidence.
- Dose
- Varies (course-based)
- How often
- Courses
Guides for this compound
- How to Reconstitute a Peptide
Mix peptide powder with bacteriostatic water, step by step.
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
- How to Vet a Peptide Vendor
Independent COAs, HPLC purity, and the red flags that mean walk away.
Sources
- Beyond Celiac, phase 3 study of larazotide acetate to treat celiac disease discontinued(2022)The CeDLara phase 3 was stopped at interim analysis. The company reported that the group size needed to show a significant difference against placebo was too large to justify continuing.
- Beyond Celiac, phase 3 celiac disease drug trial halted(2022)Larazotide was the first celiac disease candidate to reach phase 3, more than 15 years after entering clinical trials. It did not finish. Full results were never reported.
Last reviewed 8 September 2026
Beyond these, 84 records are indexed. Browse the records
